Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

Lung Cancer ◽  
2012 ◽  
Vol 78 (1) ◽  
pp. 81-86 ◽  
Author(s):  
Giulio Metro ◽  
Rita Chiari ◽  
Simona Duranti ◽  
Annamaria Siggillino ◽  
Matthias J. Fischer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Outcome ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Wild Type ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tki

Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure

Lung Cancer ◽  
2011 ◽  
Vol 74 (3) ◽  
pp. 457-461 ◽  
Author(s):  
Takehito Shukuya ◽  
Toshiaki Takahashi ◽  
Tateaki Naito ◽  
Rieko Kaira ◽  
Akira Ono ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tki

Re-biopsy in advanced non-small cell lung cancer patients after the development of 3rd generation EGFR-TKI and new targeted therapies.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e19081-e19081 ◽  
Author(s):  
Kaname Nosaki ◽  
Eiko Inamasu ◽  
Shin-ichiro Shimamatsu ◽  
Tsukihisa Yoshida ◽  
Goji Toyokawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Targeted Therapies ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tki
Sign in / Sign up

Export Citation Format

Share Document